Michel de Wilde
Director/Board Member chez VBI VACCINES INC.
Fortune : 1 005 $ au 31/03/2024
Profil
Michel de Wilde is currently an Independent Director at VBI Vaccines, Inc., a Director at VBI Vaccines (Delaware), Inc., and a Director at Verband Beratender Ingenieure VBI.
He was formerly a Director at Infectious Disease Research Institute from 2014 to 2019, an Independent Director at VBI Vaccines, Inc., and a Senior Vice President-Research & Development at Sanofi Pasteur, Inc. from 2001 to 2013.
He received a doctorate degree from Université Libre de Bruxelles in 1976 and an undergraduate degree from the same institution in 1971.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VBI VACCINES, INC.
0,01% | 27/07/2023 | 1 666 ( 0,01% ) | 1 005 $ | 31/03/2024 |
Postes actifs de Michel de Wilde
| Sociétés | Poste | Début |
|---|---|---|
| VBI VACCINES INC. | Director/Board Member | 01/05/2016 |
Verband Beratender Ingenieure VBI
 Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Director/Board Member | 01/07/2014 |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Director/Board Member | 01/07/2014 |
Anciens postes connus de Michel de Wilde
| Sociétés | Poste | Fin |
|---|---|---|
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Director/Board Member | 01/12/2019 |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Chief Tech/Sci/R&D Officer | 01/06/2013 |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Chief Tech/Sci/R&D Officer | 01/06/2013 |
| VBI VACCINES INC | Director/Board Member | - |
Formation de Michel de Wilde
| Université Libre de Bruxelles | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VBI VACCINES INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
Verband Beratender Ingenieure VBI
Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Commercial Services |
VBI Vaccines, Inc. /Old/
 VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
